These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 26660341)

  • 1. Identification of p38 MAPK and JNK as new targets for correction of Wilson disease-causing ATP7B mutants.
    Chesi G; Hegde RN; Iacobacci S; Concilli M; Parashuraman S; Festa BP; Polishchuk EV; Di Tullio G; Carissimo A; Montefusco S; Canetti D; Monti M; Amoresano A; Pucci P; van de Sluis B; Lutsenko S; Luini A; Polishchuk RS
    Hepatology; 2016 Jun; 63(6):1842-59. PubMed ID: 26660341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systems biology approach reveals new endoplasmic reticulum-associated targets for the correction of the ATP7B mutant causing Wilson disease.
    Concilli M; Iacobacci S; Chesi G; Carissimo A; Polishchuk R
    Metallomics; 2016 Sep; 8(9):920-930. PubMed ID: 27714068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin.
    van den Berghe PV; Stapelbroek JM; Krieger E; de Bie P; van de Graaf SF; de Groot RE; van Beurden E; Spijker E; Houwen RH; Berger R; Klomp LW
    Hepatology; 2009 Dec; 50(6):1783-95. PubMed ID: 19937698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Wilson disease mutations revealed that interactions between different ATP7B mutants modify their properties.
    Roy S; McCann CJ; Ralle M; Ray K; Ray J; Lutsenko S; Jayakanthan S
    Sci Rep; 2020 Aug; 10(1):13487. PubMed ID: 32778786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new Caenorhabditis elegans model to study copper toxicity in Wilson disease.
    Catalano F; O'Brien TJ; Mekhova AA; Sepe LV; Elia M; De Cegli R; Gallotta I; Santonicola P; Zampi G; Ilyechova EY; Romanov AA; Samuseva PD; Salzano J; Petruzzelli R; Polishchuk EV; Indrieri A; Kim BE; Brown AEX; Puchkova LV; Di Schiavi E; Polishchuk RS
    Traffic; 2024 Jan; 25(1):e12920. PubMed ID: 37886910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the most frequent ATP7B mutation causing Wilson disease in hepatocytes from patient induced pluripotent stem cells.
    Parisi S; Polishchuk EV; Allocca S; Ciano M; Musto A; Gallo M; Perone L; Ranucci G; Iorio R; Polishchuk RS; Bonatti S
    Sci Rep; 2018 Apr; 8(1):6247. PubMed ID: 29674751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct phenotype of a Wilson disease mutation reveals a novel trafficking determinant in the copper transporter ATP7B.
    Braiterman LT; Murthy A; Jayakanthan S; Nyasae L; Tzeng E; Gromadzka G; Woolf TB; Lutsenko S; Hubbard AL
    Proc Natl Acad Sci U S A; 2014 Apr; 111(14):E1364-73. PubMed ID: 24706876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis and drug response to zinc and D-penicillamine in stable ATP7B mutant hepatic cell lines.
    Chandhok G; Horvath J; Aggarwal A; Bhatt M; Zibert A; Schmidt HH
    World J Gastroenterol; 2016 Apr; 22(16):4109-19. PubMed ID: 27122662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective cellular localization of mutant ATP7B in Wilson's disease patients and hepatoma cell lines.
    Huster D; Hoppert M; Lutsenko S; Zinke J; Lehmann C; Mössner J; Berr F; Caca K
    Gastroenterology; 2003 Feb; 124(2):335-45. PubMed ID: 12557139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polarized trafficking and copper transport activity of ATP7B: A mutational approach to establish genotype-phenotype correlation in Wilson disease.
    Das S; Mohammed A; Mandal T; Maji S; Verma J; Ruturaj ; Gupta A
    Hum Mutat; 2022 Oct; 43(10):1408-1429. PubMed ID: 35762218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B.
    de Bie P; van de Sluis B; Burstein E; van de Berghe PV; Muller P; Berger R; Gitlin JD; Wijmenga C; Klomp LW
    Gastroenterology; 2007 Oct; 133(4):1316-26. PubMed ID: 17919502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in stability of the N-domain underlies distinct intracellular properties of the E1064A and H1069Q mutants of copper-transporting ATPase ATP7B.
    Dmitriev OY; Bhattacharjee A; Nokhrin S; Uhlemann EM; Lutsenko S
    J Biol Chem; 2011 May; 286(18):16355-62. PubMed ID: 21398519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p.H1069Q mutation in ATP7B and biochemical parameters of copper metabolism and clinical manifestation of Wilson's disease.
    Gromadzka G; Schmidt HH; Genschel J; Bochow B; Rodo M; Tarnacka B; Litwin T; Chabik G; Członkowska A
    Mov Disord; 2006 Feb; 21(2):245-8. PubMed ID: 16211609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel ATPase Cu(2+) transporting beta polypeptide mutations in Chinese families with Wilson's disease.
    Gu S; Yang H; Qi Y; Deng X; Zhang L; Guo Y; Huang Q; Li J; Shi X; Song Z; Deng H
    PLoS One; 2013; 8(7):e66526. PubMed ID: 23843956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Wilson disease: an update].
    Seo JK
    Korean J Hepatol; 2006 Sep; 12(3):333-63. PubMed ID: 16998287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wilson's Disease.
    Ferenci P
    Clin Gastroenterol Hepatol; 2005 Aug; 3(8):726-33. PubMed ID: 16233999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis.
    Polishchuk EV; Concilli M; Iacobacci S; Chesi G; Pastore N; Piccolo P; Paladino S; Baldantoni D; van IJzendoorn SC; Chan J; Chang CJ; Amoresano A; Pane F; Pucci P; Tarallo A; Parenti G; Brunetti-Pierri N; Settembre C; Ballabio A; Polishchuk RS
    Dev Cell; 2014 Jun; 29(6):686-700. PubMed ID: 24909901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and clinical features of Wilson disease.
    Ferenci P
    Metab Brain Dis; 2004 Dec; 19(3-4):229-39. PubMed ID: 15554419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoproteomics pinpoints HSP70 interaction for correction of the most frequent Wilson disease-causing mutant of ATP7B.
    Concilli M; Petruzzelli R; Parisi S; Catalano F; Sirci F; Napolitano F; Renda M; Galietta LJV; Di Bernardo D; Polishchuk RS
    Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32453-32463. PubMed ID: 33288711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An αB-Crystallin Peptide Rescues Compartmentalization and Trafficking Response to Cu Overload of ATP7B-H1069Q, the Most Frequent Cause of Wilson Disease in the Caucasian Population.
    Allocca S; Ciano M; Ciardulli MC; D'Ambrosio C; Scaloni A; Sarnataro D; Caporaso MG; D'Agostino M; Bonatti S
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.